Christian Hallermann
Overview
Explore the profile of Christian Hallermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karagiannidis I, Feldmann C, Hallermann C, Rothhaar A
Dermatologie (Heidelb)
. 2024 Dec;
76(3):186-190.
PMID: 39688687
No abstract available.
2.
Klein M, Wefers M, Hallermann C, Fischer H, Holzle F, Wermker K
Cancers (Basel)
. 2023 Aug;
15(16).
PMID: 37627115
Background: High IMP3 expression is correlated with a worse outcome. Until now, there have been no data about IMP3 expression and clinical outcome for high-risk localisation of squamous cell carcinoma...
3.
Boecker W, Reusch M, Mielke V, Reusch U, Hallermann C, Loening T, et al.
Am J Dermatopathol
. 2020 Jun;
43(2):93-102.
PMID: 32568835
Extraocular sebaceous carcinoma (ESC) is a rare appendiceal skin tumor. In contrast to ocular sebaceous carcinoma, information about the exact cellular architecture of these lesions is scarce and the histogenesis...
4.
Prinzen T, Klein M, Hallermann C, Wermker K
J Craniomaxillofac Surg
. 2019 Jul;
47(9):1370-1377.
PMID: 31331857
Introduction: Head and neck mucosal melanoma (HNMM) is a rare tumor with a poor outcome. The objective of this study was to assess outcome and prognostic factors for a cohort...
5.
Wermker K, Roknic N, Goessling K, Klein M, Schulze H, Hallermann C
Neoplasia
. 2015 Mar;
17(3):301-5.
PMID: 25810014
Objectives: Basosquamous carcinoma (BSC) is a rare tumor entity, and the most common onset is in the head and neck region (BSC-HN). The data on diagnosis, treatment, and especially risk...
6.
Teichert M, Stumpf C, Booken N, Wobser M, Nashan D, Hallermann C, et al.
Exp Dermatol
. 2015 Mar;
24(6):424-9.
PMID: 25776770
Primary cutaneous large B-cell lymphomas, leg type (PCLBCL/LT) are primary cutaneous B-cell lymphoma (PCBCL) with an intermediate prognosis. Therefore, antracycline-based polychemotherapy combined with rituximab has been recommended as first-line treatment....
7.
Wermker K, Belok F, Schipmann S, Klein M, Schulze H, Hallermann C
J Craniomaxillofac Surg
. 2015 Mar;
43(4):545-52.
PMID: 25753473
Introduction: In patients with squamous cell carcinoma (SCC) of the lip, occurrence of lymph node metastasis (LNM) is more frequent than in other cutaneous head and neck SCCs. The aim...
8.
Dettenborn T, Wermker K, Schulze H, Klein M, Schwipper V, Hallermann C
J Craniomaxillofac Surg
. 2014 Jun;
42(8):1623-8.
PMID: 24962043
Background: Cutaneous angiosarcoma of the head and neck (cAS-HN) is a rare malignancy with poor survival. Most of the histological markers and grading were not proven to be significant for...
9.
Dugas-Breit S, Schulze H, Hallermann C
J Dtsch Dermatol Ges
. 2014 Jun;
12(7):561-9.
PMID: 24889480
At the time of diagnosis primary cutaneous lymphomas are limited to the skin. T-cell lymphomas represent at least two thirds of all primary cutaneous lymphomas with mycosis fungoides and Sézary...
10.
Wermker K, Brauckmann T, Klein M, Hassfeld S, Schulze H, Hallermann C
Head Neck
. 2014 May;
37(9):1368-74.
PMID: 24817089
Background: In uncommon mucosal melanomas of the head and neck established prognostic factors are rare and controversially discussed. The purpose of this study was to evaluate outcome and value of...